# FDA Inspection 1223733 - Octapharma Plasma, Inc. - October 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/1edd51fd-a3ea-493e-87a1-c721b3fc13ca
Source feed: FDA_Inspections

> FDA Inspection 1223733 for Octapharma Plasma, Inc. on October 20, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223733
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2023-10-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1069222 - 2018-10-19](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e7fa7f80-a94f-4df3-83d9-f4c8d5762da0)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/b3033e77-ada0-42e6-afe7-c801308d68eb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d